Shares of Biomerica, Inc. (NASDAQ:BMRA – Get Free Report) passed above its 200-day moving average during trading on Friday . The stock has a 200-day moving average of $0.47 and traded as high as $0.55. Biomerica shares last traded at $0.54, with a volume of 76,444 shares changing hands.
Biomerica Trading Up 4.2 %
The stock has a market capitalization of $9.81 million, a price-to-earnings ratio of -1.57 and a beta of 0.37. The company has a fifty day moving average of $0.66 and a two-hundred day moving average of $0.47.
Biomerica (NASDAQ:BMRA – Get Free Report) last posted its earnings results on Tuesday, January 14th. The company reported ($0.06) earnings per share (EPS) for the quarter. Biomerica had a negative net margin of 100.52% and a negative return on equity of 90.19%.
Institutional Inflows and Outflows
Biomerica Company Profile
Biomerica, Inc, a biomedical technology company, develops, patents, manufactures, and markets diagnostic and therapeutic products for the detection and/or treatment of medical conditions and diseases worldwide. The company's diagnostic test kits are used to analyze blood, urine, nasal or fecal specimens from patients in the diagnosis of various diseases, food intolerances, and other medical complications; or to measure bacteria, hormones, antibodies, antigens, or other substances which may exist in the human body, stools, or blood in extremely small concentrations.
Featured Articles
- Five stocks we like better than Biomerica
- How to Use the MarketBeat Stock Screener
- JPMorgan is a Buy, if You Can Handle The Volatility
- Roth IRA Calculator: Calculate Your Potential Returns
- United States Steel’s Crash: An Unmissable Buying Opportunity
- Stock Market Upgrades: What Are They?
- Rocket Lab Stock: Weathering the Storm, Time for a Comeback?
Receive News & Ratings for Biomerica Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Biomerica and related companies with MarketBeat.com's FREE daily email newsletter.